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Abstract Sulfatide, which binds to in£uenza A viruses and
prevents the viral infection, was found to inhibit the sialidase
activities of in£uenza A viruses in a pH-dependent manner. The
kinetic parameters of the e¡ect of sulfatide on the sialidase
activities of human in£uenza A viruses using £uorometric assay
indicated that sulfatide was a powerful and non-competitive type
inhibitor in low-pH conditions.
! 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Neuramindase (NA) is one of the two surface glycoproteins
that play distinct roles in the life cycle of in£uenza A virus [1].
NA prevents the aggregation of in£uenza virus by removing
sialic acids from the sugar chain on the newly synthesized
hemagglutinin (HA) and NA. NA also promotes the release
of the progeny virus from infected cells by removing sialic
acids from host cell receptors [2]. Studies using NA-deletion
mutant viruses have indicated that viral sialidase activity is
not required for viral attachment, entry, replication or assem-
bly [3,4]. Furthermore, characterization of in£uenza A virus
mutants lacking sialidase activity that undergo multiple cycles
of replication [5,6] and HA mutants of fowl plague viruses
di¡ering only in NA subtype [7] has indicated that a balance
between HA and NA activities is important for e¡ective rep-
lication of in£uenza virus. In contrast to the biological roles
of NA in virus infection, the molecular mechanism by which
the sialidase activity of NA in the virus infection is regulated
is still not well understood.
We previously found that sulfatide binds to in£uenza A
viruses and inhibits viral infection [8]. Sulfatide, a non-sialyl-
glycolipid, is abundantly expressed at high levels in human
and animal neural tissues and in the trachea and lung [9].
This sulfate-containing glycolipid is also found in the kidney,
spleen, platelets, and gastrointestinal tract [10^12] and in cells
of Madin^Darby canine kidney (MDCK) [13], bovine kidney
(MDBK) [14], and monkey kidney (Vero), which are used for
the primary isolation and cultivation of in£uenza A viruses
[15]. Sulfatide is known to interact with extracellular matrix
proteins [12,16] and adhesion molecules [10]. Sulfatide is also
involved in the adhesion of human immunode¢ciency virus,
bacteria, and malaria parasites [9,17,18].
In the present work, we studied the e¡ects of sulfatide on
the sialidase activities of in£uenza A viruses. We found that
sulfatide inhibited the sialidase activities of in£uenza A viruses
in a pH-dependent manner and that the degree of inhibition
by sulfatide was at least 10 times greater than that by 2-de-
oxy-2,3-didehydro-N-acetyl-D-neuraminic acid (Neu5Ac2en).
2. Materials and methods
2.1. Viruses
In£uenza A viruses tested were propagated in the allantoic sac of
10-day-old embryonated eggs and were puri¢ed as described previ-
ously [8].
2.2. Lipids and NA inhibitors
Sulfatide and galactosylceramide (galactocerebroside) were pre-
pared from bovine brain gray matter as described previously [8].
2,3-Dihexadecanoyl-sn-glycero-1-phosphocholine (phosphatidylcho-
line), cholesterol, and Neu5Ac2en were purchased from Sigma, St.
Louis, MO, USA. 4-Guanidino-2-deoxy-2,3-didehydro-N-acetyl-D-
neuraminic acid (4G-Neu5Ac2en) was supplied by Glaxo Wellcome
Research and Development, Stevenage, UK.
2.3. Sialidase inhibition assay
Five Wl of each in£uenza A virus suspension (500 ng protein) in 10
mM acetate bu¡er (pH 4.0^6.0) or 10 mM phosphate bu¡er (pH 6.0^
8.0) was incubated with 5 Wl of sulfatide (3^200 WM), Neu5Ac2en (78^
5000 WM), and 4G-Neu5Ac2en (0.03^2 WM) at 37‡C for 30 min and
then incubated with 5 Wl of 4 mM 2P-(4-methylumbelliferyl)-K-D-N-
acetylneuraminic acid (4-MU-Neu5Ac) (Sigma) at 37‡C for 30 min.
The reaction was stopped by the addition of 1 ml of 100 mM car-
bonate bu¡er (pH 10.7). The £uorescence of released 4-methylumbel-
liferone (4-MU) was measured using a £uorescence spectrophotometer
(Hitachi F-4010) with excitation at 355 nm and emission at 460 nm.
The concentration causing 50% inhibition (IC50) of sialidase activity
using 4-MU-Neu5Ac was calculated graphically by plotting percent
inhibition versus inhibitor concentration.
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2.4. Preparation of liposomes bearing sulfatide
Liposomes bearing sulfatide were prepared by a modi¢ed method
previously described [16]. Sulfatide (320 nmol), phosphatidylcholine
(32 nmol), and cholesterol (320 nmol) were mixed in 500 Wl of a
solvent containing chloroform and methanol (2:1) and evaporated
to form the thin lipid ¢lm. The lipid ¢lm was vortexed in 100 mM
sodium acetate bu¡er (pH 5.0) and sonicated for 2 min. The inhibi-
tory potency of the liposome solution was examined as described
above. As controls, liposomes without glycolipids and bearing galac-
tosylceramide (galactocerebroside) were prepared in the same manner.
The assays were performed in duplicate.
3. Results
3.1. Inhibition of in£uenza A virus sialidase activity by sulfatide
We examined the e¡ects of sulfatide on the sialidase activ-
ities of N1 and N2 NA subtypes of human and avian in£u-
enza A virus strains by £uorometric assays using 4-MU-Neu5-
Ac. Sulfatide inhibited the viral sialidase activities in a pH-
dependent manner. The sialidase activities of the two human
viruses were completely inhibited by 200 WM sulfatide at pH
Fig. 1. E¡ect of pH on the inhibition of in£uenza A virus sialidase activity by sulfatide. In£uenza A virus suspension (500 ng protein) in 10
mM acetate bu¡er (pH 4.0^6.0; solid lines) or 10 mM phosphate bu¡er (pH 6.0^8.0; dotted lines) was incubated with 200 WM sulfatide (closed
circles) at 37‡C for 30 min and then incubated with 5 Wl of 4-MU-Neu5Ac at 37‡C for 30 min. The amount of released 4-MU was measured
as described in Section 2. Controls were determined under the same conditions in the absence of sulfatide (open circles). The values are the
means for duplicate experiments. A: A/Memphis-Bel (H3N1); B: A/Memphis/1/71 (H3N2); C: A/duck/Hong Kong/849/3/80 (H4N1); D: A/
duck/276/2/78 (H2N2).
Fig. 2. Inhibition of sialidase activities of in£uenza A viruses by sulfatide. Human in£uenza A virus suspension in 10 mM acetate bu¡er (pH
5.2) was incubated with sulfatide (3^200 WM; closed circles), Neu5Ac2en (0.03^2 WM; open circles), and 4G-Neu5Ac2en (0.03^2 WM; open tri-
angles) at 37‡C for 30 min and then incubated with 4-MU-Neu5Ac at 37‡C for 30 min. The sialidase activity of each in£uenza A virus is ex-
pressed as the percentage of activity relative to the activity in the absence of sulfatide. A: A/Memphis-Bel (H3N1); B: A/Memphis/1/71
(H3N2).
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values lower than pH 5.2 (Fig. 1A,B). The sialidase activities
of the two avian viruses were also completely inhibited at pH
4.0 but not at pH 5.0 (Fig. 1C,D). The kinetic parameters of
sulfatide inhibition of the viral NAs on the hydrolysis of
4-MU-Neu5Ac were determined and compared with those of
the known competitive inhibitors of sialidases, Neu5Ac2en
[19] and 4G-Neu5Ac2en [20]. The concentration causing
50% inhibition (IC50) of sialidase activity using 4-MU-Neu5-
Ac was calculated graphically by plotting percent inhibition
versus inhibitor concentration. Sulfatide proved to be a potent
inhibitor of the human in£uenza virus N1 and N2 sialidases
with IC50 values of 1.79U1034 and 1.88U1032 mM, respec-
tively, at pH 5.2 (Fig. 2). The inhibitory potency of sulfatide
was weaker than that of 4G-Neu5Ac2en (7.18U1036 and
1.32U1034 mM) but was about 10^103-fold more potent
than that of Neu5Ac2en (2.84U1031 and 3.37U1031 mM).
The kinetic parameters of the e¡ect of sulfatide on the siali-
dase activities of human in£uenza A viruses were determined
by the double-reciprocal (Lineweaver^Burk) method. The lin-
ear double-reciprocal plots indicated that sulfatide acted as a
non-competitive inhibitor (Fig. 3).
We examined whether membrane-associated sulfatide af-
fects the sialidase activity. The sialidase activity of human
in£uenza A virus was distinctly inhibited by the liposomes
containing sulfatide, relative to the liposomes without glyco-
lipids and bearing galactosylceramide (Fig. 4).
3.2. Inhibition of the sialidase activities of human, avian, swine,
and equine in£uenza A viruses by sulfatide
We examined the inhibitory e¡ect of sulfatide on NA sub-
types of in£uenza A virus isolated from humans, pigs, horses,
and birds at pH 5.2 using 4-MU-Neu5Ac as a substrate (Ta-
ble 1). The inhibition of viral sialidase activities by sulfatide at
pH 5.2 varied depending not only on the NA subtype but also
on the host animal species from which the virus was isolated.
Sialidase activities of most human, swine, and equine viruses,
with the exception of four early human viruses isolated in
1957 and 1968, were e⁄ciently inhibited by sulfatide at pH
5.2, while avian viruses varied in sensitivity to sulfatide at pH
5.2. The sialidase activities of avian N3 and N6 NA subtypes,
similar to those of the mammalian viruses, were e⁄ciently
inhibited by sulfatide at pH 5.2. In contrast, the sialidase
activities of avian N2 and N8 NA subtypes, with the excep-
tion of H9N2 viruses, retained more than 50% of the activity
under the same conditon. However, the sialidase activities of
all avian viruses tested, including N2 and N8 NA subtypes,
were e⁄ciently inhibited by sulfatide at pH 4.0 (data not
shown).
4. Discussion
Previous studies have shown that glycosaminoglycans and
sulfated compounds inhibited many human lysosomal en-
zymes and bacterial sialidases [21^24]. In the present study,
Fig. 3. Lineweaver^Burk plots of inhibition of in£uenza A virus sialidase activity by sulfatide. The sialidase activity of each in£uenza A virus
with various concentrations of 4-MU-Neu5Ac in the presence of sulfatide (closed circles) or Neu5Ac2en (closed triangle) or in the absence of
the inhibitor (open circles) was measured as described in Section 2. A: A/Memphis-Bel (H3N1); B: A/Memphis/1/71 (H3N2).
Fig. 4. Inhibition of the sialidase activity of in£uenza A virus by
the liposomes bearing sulfatide. Human in£uenza virus A/Memphis/
1/71 (H3N2) suspension in 10 mM acetate bu¡er (pH 5.2) was incu-
bated with liposomes containing sulfatide (20^320 nmol/ml; closed
circles), galactosylceramide (20^320 nmol; open circles), and without
glycolipids (open triangle) at 37‡C for 30 min and then incubated
with 4-MU-Neu5Ac at 37‡C for 30 min. The sialidase activity of
each in£uenza A virus is expressed as the percentage of activity rela-
tive to the activity in the absence of the liposomes.
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we found that sulfatide e⁄ciently inhibited sialidase activities
of in£uenza A virus NAs under conditions of less than pH
6.0. In contrast, galactosylceramide, the biosynthetic precur-
sor of sulfatide, did not inhibit the sialidase activities of the
viruses. In the basic amino acids, only histidine (pKR =6.0)
carries an imidazolium moiety and ionizes under conditions of
less than pH 6.0. The results suggest that the inhibition of the
sialidase activity was caused by interaction of the sulfate ga-
lactose of sulfatide with the side chain of histidines in NAs.
For example, histidines at positions 144, 150, 155, 164, 189,
191, 264, and 274 in human N2 NAs are highly conserved
among human N2 NAs tested. Above all, the binding of sul-
fatide to histidine at position 150, which is located by the
enzyme active site, may a¡ect the enzymatic activity of the
NA. We found that chondroitin sulfates (A and B) and dex-
tran sulfate also inhibited the sialidase activity of in£uenza A
virus. On the other hand, the sialidase activity was little af-
fected by sulfated monosaccharides under the same conditions
(data not shown). These results show that the inhibitory e¡ect
of sulfated glycoconjugates on the sialidase activity is remark-
Table 1
Inhibition of the sialidase activities of in£uenza A viruses at pH 5.2 by sulfatide
Virus Sialidase activity
(4-MU released pmol/min){{decimal:split}}T S
Sialidase inhibition (%)
Control Sulfatide
Human isolates
A/Singapore/1/57 (H2N2) 33.6T 0.4 23.5T 0.1 30.0
A/Japan/305/57 (H2N2) 120.7T 1.3 109.3T 0.2 9.4
A/Hong Kong/1/68 (H3N2) 43.2T 0.6 25.0T 0.4 42.2
A/Aichi/2/68 (H3N2) 31.4T 0.4 13.0T 0.1 58.6
A/Memphis/1/71 (H3N2) 20.2T 0.7 1.1 T 0.1 94.7
A/Memphis/102/72 (H3N2) 28.1T 0.4 0.5 T 0.0 98.1
A/Tokyo/6/73 (H3N2) 39.3T 2.0 0.4 T 0.1 99.1
A/Kumamoto/55/76 (H3N2) 32.3T 3.1 0.2 T 0.0 99.3
A/Texas/1/77 (H3N2) 23.0T 1.7 0.4 T 0.0 98.4
A/Yamanashi/2/77 (H3N2) 9.7 T 0.7 0.6 T 0.2 94.1
A/Bangkok/1/79 (H3N2) 25.0T 1.6 6.8 T 0.5 72.8
A/Victoria/2/82 (H3N2) 13.0T 0.9 0.3 T 0.0 98.1
Avian isolates
A/duck/Alberta/35/76 (H1N1) 177.2T 2.5 61.0T 4.4 65.6
A/duck/Hong kong/36/4/76 (H1N1) 66.2T 0.8 23.4T 0.8 64.7
A/duck/Hong kong/849/3/80 (H4N1) 125.5T 19 114.8T 3.8 8.6
A/duck/Hong kong/13/2/76 (H6N1) 159.7T 1.3 14.0T 1.4 91.2
A/duck/Hong kong/33/3/76 (H10N1) 294.0T 0.3 149.5T 17 49.1
A/duck/Hong kong/273/8/78 (H2N2) 234.8T 0.9 198.1T 0.4 15.6
A/duck/Hong kong/276/2/78 (H2N2) 44.4T 1.1 33.4T 0.2 24.7
A/duck/Hong kong/24/5/76 (H3N2) 175.6T 2.2 130.5T 0.0 25.7
A/duck/Hong kong/47/5/76 (H7N2) 171.6T 2.1 119.4T 4.3 30.4
A/duck/Hong kong/86/1/76 (H9N2) 107.2T 1.6 4.2 T 0.2 96.0
A/duck/Hong kong/92/1/76 (H9N2) 47.0T 0.2 5.5 T 0.1 88.4
A/duck/Hong kong/717/8/79 (H1N3) 72.5T 4.2 10.0T 0.9 86.1
A/duck/Hong kong/313/4/78 (H5N3) 177.2T 5.4 2.6 T 0.5 98.5
A/duck/Hong kong/44/3/76 (H11N3) 89.5T 0.9 0.9 T 0.2 99.0
A/teal/Alberta/69/87 (H1N4) 32.9T 0.6 9.7 T 0.7 70.4
A/mallard/Alberta/58/89 (H6N4) 12.5T 0.3 7.5 T 0.2 39.9
A/mallard/Alberta/7/87 (H8N4) 15.5T 0.9 4.4 T 0.3 71.8
A/duck/Hong kong/668/3/79 (H4N5) 175.6T 0.9 10.9T 0.4 93.8
A/duck/Hong kong/862/5/80 (H12N5) 33.7T 1.1 29.5T 0.1 12.6
A/duck/Hong kong/526/3B/79 (H3N6) 10.3T 0.6 2.0 T 0.1 80.7
A/mallard/Alberta/25/85 (H4N6) 18.6T 0.5 2.0 T 0.1 89.3
A/duck/Hong kong/200/1/77 (H4N6) 125.5T 0.6 41.5T 1.2 66.9
A/duck/Hong kong/219/1/77 (H4N6) 72.5T 9.5 5.9 T 0.1 91.8
A/duck/Ukraina/1/63 (H3N8) 63.6T 6.5 40.1T 0.8 36.9
A/duck/Hokkaido/8/80 (H3N8) 66.2T 5.4 40.3T 3.1 39.2
A/mallard/Alberta/23/89 (H3N8) 40.5T 1.9 20.8T 1.2 48.5
A/duck/Hong kong/278/5/78 (H2N9) 63.6T 2.8 13.4T 0.5 78.9
A/mallard/Alberta/24/92 (H11N9) 9.6 T 0.3 4.0 T 0.7 58.1
Swine isolates
A/swine/Wisconsin/15/30 (H1N1) 3.8 T 0.1 0.8 T 0.0 80.1
A/swine/Hong Kong/168/93 (H1N1) 144.1T 1.9 10.5T 0.4 92.7
A/swine/Colorado/1/77 (H3N2) 14.6T 0.6 1.3 T 0.1 90.9
A/swine/Hokkaido/10/85 (H3N2) 22.1T 0.6 5.1 T 0.5 76.8
Equine isolates
A/equine/Prague/56 (H7N7) 27.5T 1.3 13.5T 0.3 50.9
A/equine/London/1416/73 (H7N7) 18.0T 0.2 5.9 T 0.1 67.2
A/equine/Fontainebleau/79 (H3N8) 12.3T 0.9 0.4 T 0.0 97.1
A/equine/Tennessee/5/86 (H3N8) 16.8T 0.3 2.0 T 0.1 87.9
Each in£uenza A virus suspension (500 ng protein) in 10 mM acetate bu¡er (pH 5.2) was incubated with 1 nmol sulfatide at 37‡C for 30 min
and then the mixture was incubated with 4-MU-Neu5Ac at 37‡C for 30 min as described in Section 2. The amount of released 4-MU was mea-
sured using a £uorescence spectrophotometer. The degree of sialidase inhibition is expressed as a percentage inhibition of each enzyme activity.
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ably dependent on the topology of sulfate sugar in the mole-
cules.
Duck strains varied in sensitivity to sulfatide at pH 5.2;
however, the sialidase activities of all duck viruses tested
were e⁄ciently inhibited by sulfatide at pH 4.0. In previous
studies, we found that NAs of 1957 and 1968 human pan-
demic in£uenza A virus strains as well as duck viruses re-
tained their sialidase activities even at pHs of less than 4.5,
but not NAs of the epidemic strains isolated after 1968 and
swine strains tested [25,26]. E¡ect of pH values on the siali-
dase inhibition of the mammalian and duck N2 NAs by sulfa-
tide correlated with low-pH stability of their sialidase activ-
ities. On the other hand, the e¡ect of pH values on other duck
sialidase inhibition by sulfatide did not coincide with their pH
stability. The results indicate that the mechanism of NA in-
hibition by sulfatide is di¡erent from the mechanism contrib-
uting to their low pH stability.
Duck viruses replicate in the intestinal tract through the
digestive tract of ducks. The di¡erence in their sensitivity to
sulfatide between duck and mammalian viruses may therefore
depend on their target tissues.
Sulfatide was synthesized through the endoplasmic reticu-
lum and Golgi apparatus, from which it was transported by
membrane vesicle to the plasma membrane and other intra-
cellular organelles, like lysosomes [27,28]. Interestingly, some
of the main sorting organelles, such as lysosomes and the
trans-Golgi network, in cells are known to be acidi¢ed. For
example, lysosomes maintained a pH 4.0^5.0 [29]. The pH in
the trans-Golgi network in virus-infected chicken embryo ¢-
broblasts or MDCK cells has been shown to be approximately
5.2 and 5.6 [30]. The studies suggest that sulfatide can a¡ect
NA in lysosomes or trans-Golgi network. Further studies are
needed to characterize the role of sulfatide in in£uenza virus
infections.
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